Abstract
In a recent study we reported increased expression of IL-17A in the lung of patients with lung adenocarcinoma. Local blockade of IL-17A in the lung, in a model of lung cancer revealed enhanced anti-tumor immunity characterized by increased IFNγ, a diminished T-regulatory cell number and reduced tumor growth. © 2012 Landes Bioscience.
Author supplied keywords
Cite
CITATION STYLE
APA
Reppert, S., Koch, S., & Finotto, S. (2012). IL-17A is a central regulator of lung tumor growth. OncoImmunology, 1(5), 783–785. https://doi.org/10.4161/onci.19735
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free